Moscoso SB,
Mendoza F, Gómez LA, Londoño A, Marín JS, Sarmiento JM, Cortes F,
Vargas-Sanchez PK, Díaz-Báez D, Lafaurie GI. Incidence of bleeding during and
after two non-surgical periodontal therapy schemes in patients with recent
acute coronary syndrome on dual antiplatelet therapy: A pilot studys. J Clin
Exp Dent. 2024;16(12):e1495-1502.
doi:10.4317/jced.61758
https://doi.org/10.4317/jced.61758
_____
References
1. Virani SS, Newby LK, Arnold SV,
Bittner V, Brewer LC, Demeter SH, et al. 2023 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA
guideline for the management of patients with chronic coronary disease: A
report of the American Heart Association/American College of Cardiology joint
committee on clinical practice guidelines. Circulation. 2023;148:e9-e119. |
|
|
|
2. Taylor RS, Dalal HM, McDonagh
STJ. The role of cardiac rehabilitation in improving cardiovascular outcomes.
Nat Rev Cardiol. 2022;19:180-194. |
|
|
|
3. Gulati M, Levy PD, Mukherjee D,
Amsterdam E, Bhatt DL, Birtcher KK. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR
guideline for the evaluation and diagnosis of chest pain: A report of the
American College of Cardiology/American Heart Association joint committee on
clinical practice. Circulation. 2021;30:e455. |
|
|
|
4. Majithia A, Bhatt DL.Novel
antiplatelet therapies for atherothrombotic diseases. Arterioscler Thromb
Vasc Biol. 2019;39:546-557. |
|
|
|
5. Skaar D, O'Connor H, Lunos S,
Luepker R, Michalowicz BS. Dental procedures and risk of experiencing a
second vascular event in a Medicare population. J Am Dent Assoc. 2012;143:1190-1198. |
|
|
|
6. Douketis JD, Spyropoulos AC,
Spencer FA, Mayr M, Jaffer AK, Eckman MH, et al. Perioperative management of
antithrombotic therapy: Antithrombotic therapy and prevention of thrombosis,
9th ed: American College of chest physicians evidence-based clinical practice
guidelines. Chest. 2012;141:e326S-e350S. |
|
|
|
7. Baron TH, Kamath PS, McBane RD.
Management of antithrombotic therapy in patients undergoing invasive
procedures. N Engl J Med. 2013;368:2113-2124. |
|
|
|
8. Dorn JM, Genco RJ, Grossi SG,
Falkner KL, Hovey KM, Iacoviello L, Trevisan M. Periodontal disease and
recurrent cardiovascular events in survivors of myocardial infarction (MI):
the Western New York Acute MI Study. J Periodontol. 2010;81:502-511. |
|
|
|
9. Wagner AK, D'Souza M, Bang CN,
Holmstrup P, Blanche P, Fiehn NE, et al. Treated periodontitis and recurrent
events after first-time myocardial infarction: A Danish nationwide cohort
study. J Clin Periodontol. 2023;50:1305-1314. |
|
|
|
10. Pickett FA. New guidelines for
cardiac risk assessment prior to non-cardiac surgery. Int J Dent Hyg. 2010;8:147-149. |
|
|
|
11. Gulati M, Levy PD, Mukherjee
D, Amsterdam E, Bhatt DL, Birtcher KK. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR
guideline for the evaluation and diagnosis of chest pain: A report of the
American College of Cardiology/American Heart Association joint committee on
clinical practice guidelines. Circulation. 2021;30:e368-e454. PMid:34709879 |
|
|
|
12. Tonetti MS, Greenwell H,
Kornman KS. Staging and grading of periodontitis: framework and proposal of a
new classification and case definition. J Periodontol. 2018;89(suppl
1):S159-S172. |
|
|
|
13. Doganay O, Atalay B, Karadag
E, Aga U, Tugrul M. Bleeding frequency of patients taking ticagrelor,
aspirin, clopidogrel, and dual antiplatelet therapy after tooth extraction
and minor oral surgery. J Am Dent Assoc. 2018;149:132-138. |
|
|
|
14. Lillis T, Ziakas A, Koskinas
K, Tsirlis A, Giannoglou G. Safety of dental extractions during uninterrupted
single or dual antiplatelet treatment. Am J Cardiol. 2011;108:964-967. |
|
|
|
15. Yong CW, Tan SHX, Teo GN, Tan
TS, Ng WH. Should we stop dual anti-platelet therapy for dental extractions?
An umbrella review for this dental dilemma. J Stomatol Oral Maxillofac Surg.
2022;123:e708-e716. |
|
|
|
16. Rubino RT, Dawson DR 3rd, Kryscio
RJ, Al-Sabbagh M, Miller CS. Postoperative bleeding associated with
antiplatelet and anticoagulant drugs: A retrospective study. Oral Surg Oral
Med Oral Pathol Oral Radiol. 2019;128:243-249. |
|
|
|
17. Akkaif MA, Sha'aban A, Daud
NAA, Yunusa I, Ng ML, Sk Abdul Kader MA, Noor DAM, Ibrahim B. Coronary Heart
Disease (CHD) in elderly patients: which drug to choose, ticagrelor and
clopidogrel? a systematic review and meta-analysis of randomized controlled
trials. J Cardiovasc Dev Dis. 2021;8(10):123. |
|
|
|
18. Gimbel M, Qaderdan K,
Willemsen L, Hermanides R, Bergmeijer T, de Vrey E, et al. Clopidogrel versus
ticagrelor or prasugrel in patients aged 70 years or older with
non-ST-elevation acute coronary syndrome (POPular AGE): the randomised,
open-label, non-inferiority trial. Lancet. 2020;395:1374-1381. |